At ASCO 2025, artificial intelligence took center stage as a real-world solution to one of oncology’s most complex challenges: sequencing treatments in a rapidly expanding biomarker landscape.
In a recent PharmaLive article, Tim Lewis, EVP of Strategic Development, Oncology and Precision Medicine at EVERSANA INTOUCH, shared how AI is helping oncologists make faster, smarter decisions when evidence is limited and complexity is high.
“AI will not replace oncologists, but it is increasingly becoming an indispensable tool to extend their reach.” — Tim Lewis
From real-world imaging to dynamic therapy adjustment, Tim explores how AI is reshaping oncology decision-making—and what that means for the future of personalized care.
Our oncology expertise and experience with Artful Ingenuity — the fusion of technology, human insight, and innovation — translate high science into empathetic storytelling that enhances HCP and patient engagement to maximize your brand’s impact.
Tap into our Oncology Center of Excellence for expert guidance and AI-powered solutions that close engagement gaps, improve outcomes, and elevate your oncology strategy.
For a deeper dive into these insights and more, be sure to read the full article by Tim Lewis on PharmaLive.